Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hectorol Dose Conversion in SHPT
NCT00418600Phase 4Completed
- Sponsor
- Sanofi
- Start
- Nov 2006
- Primary completion
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of doxercalciferol in secondary hyperparathyroidism (SHPT), sponsored by Sanofi. Started Nov 2006; status: completed.
02
Drugs
doxercalciferol
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on NCT00418600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00418600.